Welcome to LookChem.com Sign In|Join Free
  • or
1H-Indazol-3-amine, N-(4-bromophenyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

461698-95-3

Post Buying Request

461698-95-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

461698-95-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 461698-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,6,1,6,9 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 461698-95:
(8*4)+(7*6)+(6*1)+(5*6)+(4*9)+(3*8)+(2*9)+(1*5)=193
193 % 10 = 3
So 461698-95-3 is a valid CAS Registry Number.

461698-95-3Downstream Products

461698-95-3Relevant academic research and scientific papers

Synthesis of N-aryl-3H-indazol-3-imine and N-aryl-1H-indazol-3-amine via Na2WO4/H2O2 mediated by intramolecular N–N coupling

Sajadi, Mahdieh Sadat,Darehkordi, Ali,Hosseini, Seyed Mohammad Sadegh

, (2021/03/01)

A fast and convenient method for synthesis of N-aryl-1H-indazol-3-amine and N-aryl-3H-indazol-3-imine compounds has been described via intramolecular oxidative cyclization of the 2-amino-Nˊ-arylbenzimidamide intermediates by Na2WO4/H2O2 in excellent yields. This procedure has several advantages such as mild reaction conditions, short reaction time, and excellent yields, making this methodology practical.

Pyrazolopyrimidines as therapeutic agents

-

, (2008/06/13)

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

Pyrazolopyrimidines as therapeutic agents

-

Page/Page column 72, (2010/11/30)

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, and R3 are defined as described herein.

Pyrazolopyrimidines as therapeutic agents

-

, (2008/06/13)

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 461698-95-3